Preotact after a brEAK

Trial Profile

Preotact after a brEAK

Phase of Trial: Phase III

Latest Information Update: 25 Oct 2007

At a glance

  • Drugs Parathyroid hormone (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PEAK
  • Most Recent Events

    • 25 Oct 2007 Preliminary results in the first 125 patients have been reported at ASBMR 2007.
    • 24 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top